United States - English - NLM (National Library of Medicine)

vertical pharmaceuticals inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), sodium ascorbate (unii: s033eh8359) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyrid - ascorbic acid 50 mg - ob complete™ chewable is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Canada - English - Health Canada

vita health products inc - vitamin a (retinol palmitate); vitamin b1 (thiamine mononitrate); vitamin b2; vitamin b6 (pyridoxine hydrochloride); vitamin b12; ascorbic acid (sodium ascorbate); vitamin d; folic acid; nicotinamide; biotin; vitamin e (dl-alpha tocopheryl acetate); d-pantothenic acid (calcium d-pantothenate); calcium (calcium phosphate (dibasic)); copper (cupric oxide); iron (ferrous fumarate); phosphorus (calcium phosphate (dibasic)) - tablet - 5000unit; 1.5mg; 1.5mg; 1mg; 3mcg; 50mg; 400unit; 0.1mg; 15mg; 30mcg; 10unit; 10mg; 160mg; 1mg; 4mg; 125mg - vitamin a (retinol palmitate) 5000unit; vitamin b1 (thiamine mononitrate) 1.5mg; vitamin b2 1.5mg; vitamin b6 (pyridoxine hydrochloride) 1mg; vitamin b12 3mcg; ascorbic acid (sodium ascorbate) 50mg; vitamin d 400unit; folic acid 0.1mg; nicotinamide 15mg; biotin 30mcg; vitamin e (dl-alpha tocopheryl acetate) 10unit; d-pantothenic acid (calcium d-pantothenate) 10mg; calcium (calcium phosphate (dibasic)) 160mg; copper (cupric oxide) 1mg; iron (ferrous fumarate) 4mg; phosphorus (calcium phosphate (dibasic)) 125mg - vitamins & minerals

Canada - English - Health Canada

quest vitamins a div of purity life health products - vitamin d3; ascorbic acid (sodium ascorbate); vitamin b1 (thiamine mononitrate); vitamin a (retinol palmitate); vitamin b2 (riboflavin); nicotinamide; vitamin b6 (pyridoxine hydrochloride); folic acid; vitamin b12 - tablet - 400unit; 50mg; 1.5mg; 5000unit; 1.5mg; 15mg; 1mg; 0.1mg; 3mcg - vitamin d3 400unit; ascorbic acid (sodium ascorbate) 50mg; vitamin b1 (thiamine mononitrate) 1.5mg; vitamin a (retinol palmitate) 5000unit; vitamin b2 (riboflavin) 1.5mg; nicotinamide 15mg; vitamin b6 (pyridoxine hydrochloride) 1mg; folic acid 0.1mg; vitamin b12 3mcg - multivitamin preparations

United States - English - NLM (National Library of Medicine)

flon laboratories llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid

United States - English - NLM (National Library of Medicine)

raw materials international overseas llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - vitamin c = ascorbic acid - parenteral liquid/solution/suspension - vitamin c = ascorbic acid vitamin-c active 500.0 mg/ml - nutrition & metabolism - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - vitamin deficiency | prevention & treatment of anae | treatment of basal metabolic d | treatment of debility & anorex

United States - English - NLM (National Library of Medicine)

salix pharmaceuticals, inc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - plenvu® is indicated for cleansing of the colon in preparation for colonoscopy in adults. plenvu is contraindicated in the following conditions: risk summary there are no available data with plenvu in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with plenvu. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data available to assess the presence of plenvu in human milk, the effects on the breastfed child or the effects on milk production. the lack of clinical data during lactation precludes a clear determination of the risk of plenvu to a child during lactation; therefore

Canada - English - Health Canada

pharmavite llc - ascorbic acid (sodium ascorbate, ascorbic acid) - tablet - 250mg - ascorbic acid (sodium ascorbate, ascorbic acid) 250mg - vitamin c

United States - English - NLM (National Library of Medicine)

salix pharmaceuticals, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol 3350 100 g in 1 l - moviprep® is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. moviprep is contraindicated in the following conditions: risk summary there are no available data on moviprep in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with moviprep. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data available on the presence of moviprep in human milk, the effects of the drug on the breastfed child, or the effects of the drug on milk production. the lack of clinical data during lactation precludes a clear determination of the risk o

United States - English - NLM (National Library of Medicine)

clipper distributing company llc - sodium ascorbate (unii: s033eh8359) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 250 mg in 1 ml - injectable solution caution: federal law restricts this drug to use by or on the order of a licensed veterinarian. for animal use only keep out of reach of children indications for use as a nutritive supplement of vitamin c in cattle, horses, sheep, swine, dogs and cats.